× Digital News Videos Opinions Cartoons Education E-Paper Lifestyle & Entertainment Nairobian Entertainment Eve Woman Travelog TV Stations KTN Home KTN News BTV KTN Farmers TV Radio Stations Radio Maisha Spice FM Vybez Radio Enterprise VAS E-Learning Digger Classified The Standard Group Corporate Contact Us Rate Card Vacancies DCX O.M Portal Corporate Email RMS
Indian firm Cipla will distribute remdesivir in Kenya, an antiviral drug that could be critical in the management of Covid-19.

Cipla entered into an agreement with America’s Gilead Sciences, which owns the patent for the drug, granting it a licence to manufacture and distribute the drug in 127 countries, including Kenya.

Remdesivir received the Emergency Use Authorisation for treating Covid-19 by the US Food and Drug Administration on May 1. "Cipla will make remdesivir available in Kenya at a significantly reduced price,” said Martin Sweeney, Commercial head of Cipla in Sub-Saharan Africa.

Covid 19 Time Series


remdesivir Cipla Covid-19
Share this story

Read More